Clinical findings in children with cutaneous anthrax in eastern Turkey

Pediatric Dermatology

Volumn 27, Issue 6, 2010, Pages 600-606

  Akbayram, Sinan ^a   Doǧan, Murat ^a   Akgün, Cihangir ^a   Peker, Erdal ^a   Selcuk Bektas M ^a   Kaya, Avni ^a   Çaksen, Hüseyin ^a   Öner, Ahmet Faik ^a  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMIKACIN PLUS CEFAZOLIN SODIUM; CIPROFLOXACIN; ETHACRIDINE LACTATE; PENICILLIN G; PREDNISOLONE; PROCAINE PENICILLIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTHRAX; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL SKIN DISEASE; BACTERIUM CULTURE; CHILD; CLINICAL EXAMINATION; FEMALE; GRAM STAINING; HUMAN; INFANT; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; PENICILLIN ALLERGY; PRESCHOOL CHILD; PRIORITY JOURNAL; PUSTULE; SCHOOL CHILD; SECONDARY INFECTION; SKIN EDEMA; TURKEY (REPUBLIC);

ADOLESCENT; ANTHRAX; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DERMATITIS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; RECONSTRUCTIVE SURGICAL PROCEDURES; RETROSPECTIVE STUDIES; TURKEY;

EID: 78650088152     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2010.01214.x     Document Type: Article

References (30)

1. Lew DP,. Bacillus anthracis (anthrax). In:, Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases, 5th ed. New York: Churchill Livingstone, Inc., 2000.
2. World Health Organization. Guidelines for the Surveillance and Control of Antrax in Humans and Animals. Accessed on October 2, 2003.
3. World Health Organization. Anthrax control and research, with special reference to national programme development in Africa: memorandum from a WHO meeting. Bull World Health Organ 1994; 72: 13-22.
4. Doǧanay M, Aygen B,. Diagnosis: cutaneous anthrax. Clin Infect Dis 1997; 25: 725.
5. Friedlander AM,. Anthrax: clinical features, pathogenesis, and potential biological warfare threat. In:, Remington JS, Swartz MN, eds. Current clinical topics in infectious diseases. Malden: Blackwell Science, Inc., 2000.
6. Doganay M,. Bacillus anthracis ve diger bacillus turleri. In:, Topçu AW, Söyletir G, Doǧanay M, eds. Infeksiyon hastaliklari ve mikrobiyolojisi, 2nd ed. Istanbul: Nobel Tip Kitabevi, Inc., 2002.
7. Hugh-Jones M,. 1996-97 global anthrax report. J Appl Microbiol 1999; 87: 189-191.
8. Velimirovic B,. Anthrax in Europe. Rev Sci Tech Off Int Epiz 1984; 3: 527.
9. Doǧanay M, Aydin N,. Antimicrobial susceptibility of Bacillus anthracis. Scand J Infect Dis 1991; 23: 333-335.
10. Irmak H, Buzgan T, Karahocagil MK, et al. Cutaneous manifestations of anthrax in eastern Anatolia: a review of 39 cases. Acta Med Okayama 2003; 57: 235-240.
11. Demirdag K, Ozden M, Saral Y, et al. Cutaneous anthrax in adults: a review of 25 cases in the eastern Anatolian region of Turkey. Infection 2003; 31: 327-330.
12. Oncül O, Ozsoy MF, Gul HC, et al. Cutaneous anthrax in Turkey: a review of 32 cases. Scand J Infect Dis 2002; 34: 413-416.
13. Caksen H, Arabaci F, Abuhandan M, et al. Cutaneous anthrax in eastern Turkey. Cutis 2001; 67: 488-492.
14. Caksen H, Atas B, Odabas D, et al. Anthrax of the eyelid in a Turkish girl. Pediatr Dermatol 2003; 20: 93-94.
15. Spencer RC,. Bacillus anthracis. J Clin Pathol 2003; 56: 182-187.
16. Swartz MN,. Recognition and management of anthrax-an update. N Engl J Med 2001; 345: 1621-1626.
17. Tutrone WD, Scheinfeld NS, Weinberg JM,. Cutaneous anthrax: a concise review. Cutis 2002; 69: 27-33.
18. Samad MA, Hoque ME,. Anthrax in man and cattle in Bangladesh. J Trop Med Hyg 1986; 89: 43-45.
19. Inglesby TV, O'Toole T, Henderson DA, et al. Working Group on Civilian Biodefense. Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA 2002; 287: 2236-2252.
20. Karahocagil MK, Akdeniz N, Akdeniz H, et al. Cutaneous anthrax in eastern Turkey: a review of 85 cases. Clin Exp Dermatol 2008; 33: 406-411.
21. Ozcan H, Kayabas U, Bayindir Y, et al. Evaluation of 23 cutaneous anthrax patients in eastern Anatolia, Turkey: diagnosis and risk factors. Int J Dermatol 2008; 47: 1033-1037.
22. Bravata DM, Wang E, Holty JE, et al. Pediatric anthrax: implications for bioterrorism preparedness. Evid Rep Technol Assess (Full Rep) 2006; 141: 1-48.
23. Mwenye KS, Siziya S, Peterson D,. Factors associated with human anthrax outbreak in the Chikupo and Ngandu villages of Murewa district in Mashonaland East Province, Zimbabwe. Cent Afr J Med 1996; 42: 312-315.
24. Pile JC, Malone JD, Eitzen EM, et al. Anthrax as a potential biological warfare agent. Arch Intern Med 1998; 158: 429-434.
25. Bell DM, Kozarsky PE, Stephens DS,. Clinical issues in the prophylaxis, diagnosis, and treatment of anthrax. Emerg Infect Dis 2002; 8: 222-225.
26. Turnbull PC, Doganay M, Lindeque PM, et al. Serology and anthrax in humans, livestock and Etosha National Park wildlife. Epidemiol Infect 1992; 108: 299-313.
27. Sirisanthana T, Nelson KE, Ezzell JW, et al. Serological studies of patients with cutaneous and oral-oropharyngeal anthrax from northern Thailand. Am J Trop Med Hyg 1988; 39: 575-581.
28. Dixon TC, Meselson M, Guillemin J, et al. Anthrax. N Engl J Med 1999; 341: 815-826.
29. Maguiña C, Flores Del Pozo J, Terashima A, et al. Cutaneous anthrax in Lima, Peru: retrospective analysis of 71 cases, including four with a meningoencephalic complication. Rev Inst Med Trop Sao Paulo 2005; 47: 25-30.
30. Centers for Disease Control and Prevention (CDC). Update: interim recommendations for antimicrobial prophylaxis for children and breastfeeding mothers and treatment of children with anthrax. MMWR Morb Mortal Wkly Rep 2001; 50: 1014-1016.